News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Research Is The Reason Nicole Seagriff had options to treat her breast cancer – The Breast Cancer Research Foundation
The Breast Cancer Research Foundation
Nov 13, 2024, 08:36

Research Is The Reason Nicole Seagriff had options to treat her breast cancer – The Breast Cancer Research Foundation

“As a two-time breast cancer survivor and president of The Pink Agenda, Nicole Seagriff has seen the power of research firsthand.

Research Is The Reason she had options to treat her breast cancer and can now raise awareness and funds for research to investigate the disease in younger women. 

Click here to read her story.”

Research Is The Reason Nicole Seagriff had options to treat her breast cancer - The Breast Cancer Research Foundation

Breast Cancer cancer Nicole Seagriff OncoDaily Oncology The Breast Cancer Research Foundation The Pink Agenda
Special Coverage
Blog
Jun 19, 2025, 16:12
World Kidney Cancer Day 2025: Uniting for Progress in the Fight Against Renal Cell Carcinoma
Blog
Jun 19, 2025, 16:01
IARC Marks World Kidney Cancer Day with New Video and Project Highlights
Science
Jun 19, 2025, 15:50
Alexey Kulikov Shared An Article on Cancer Vaccines and The Future of Immunotherapy
Opinion
Jun 19, 2025, 15:47
Mostafa Faisal: Primary Refractory AML and Allo-HCT - A 10-Year Retrospective Study from Japan
Blog
Jun 19, 2025, 15:36
Amol Akhade: KEYNOTE-689 - A Turning Point in Resectable HNSCC - Or a Cautious Step Forward?
Drugs
Jun 19, 2025, 15:30
Graham Collins: Nivo-AVD vs BV-AVD in Older Patients (60+) with Hodgkin Lymphoma
Blog
Jun 19, 2025, 15:15
Antonio Jimenez Jimenez Shared Findings from the Multicenter ACCESS trial, Supported by CIBMTR and NMDP
Blog
Jun 19, 2025, 14:35
Peter Pisters: Pleased to Join the 1st Institute for Cell Therapy Discovery and Innovation's External Advisory Board meeting
Insight
Jun 19, 2025, 14:22
Ron Alfa: Noetik and Agenus Announced an Exciting Collaboration to Deploy Foundation Models to Predict Immunotherapy Response
Blog
Jun 19, 2025, 13:42
Raffaele Colombo: Preclinical development of DB-1419 published on Clinical Cancer Research AACR
Blog
Jun 19, 2025, 13:21
Mohamed Kharfan-Dabaja: Happy to Share Our Clinical Practice Recommendations in CLL on behalf of ASTCT
Oncolibrary
Jun 19, 2025, 13:13
New Paper Alert: KEYNOTE-689. Neoadjuvant and Adjuvant Pembrolizumab Improves Survival in Locally Advanced HNC